AI Agents
Desktop
API & Integration
Pricing
Blog
AI Agents
IP Search Agents
Novelty Search
FTO Search
Design FTO Search
IP Drafting Agents
SEP Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
SAR Data Extraction
Lead Compound
Materials Agents
Desktop
API & Integration
Pricing
Blog
IP Search Agents
Novelty Search
FTO Search
Design FTO Search
IP Drafting Agents
SEP Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
SAR Data Extraction
Lead Compound
Materials Agents
Eureka Desktop Now Available
Download now
Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
3
results about "Tumour therapy" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Electrode arrangement for the application of tumor treatment fields (TTfields) with a graphite film
Active
DE602022037919T2
Antibody medical ingredients
External electrodes
Paranasal Sinus Carcinoma
Treatment field
Owner:
NOVOCURE GMBH
Use of nitroreductase inhibitors for the preparation of a medicament for the treatment of prostate cancer
Pending
CN122440839A
Flutamide
Escherichia coli
The application discloses application of a
nitroreductase
inhibitor in preparation of a
drug
for treating
prostate
cancer
, and relates to the technical field of tumor treatment. The application provides application of the
nitroreductase
inhibitor in preparation of a
drug
for preventing and / or treating
prostate
cancer
in combination with flutamide, the
nitroreductase
inhibitor can inhibit
metabolism
of flutamide, and
elimination
of
escherichia
coli can improve the antitumor effect of flutamide.
View all
Owner:
ZHEJIANG CANCER HOSPITAL
Use of selective vegfr3 inhibitors in combination with anti-pd-l1 antibodies in the treatment of lung cancer
Pending
CN122342811A
Antiendomysial antibodies
Treatment of lung cancer
The present application relates to the field of tumor treatment, and particularly relates to a combination of a selective VEGFR3 inhibitor and an anti-PD-L1
antibody
and application thereof in
lung
cancer
treatment.
View all
Owner:
GUANGZHOU NAT LAB
Login to View More
Popular searches
Graphite
Oncology
Biomedical engineering
Cancer research
Electrode
Prostate cancer
Pharmaceutical drug
Pharmaceutical Substances
Anti neoplastic
Metabolism